A strategic thinking of the scientific system of drug regulatory in China - advancing drug standards of China

被引：0
|
作者：
Fucheng Zhou
机构：
[1] Pharmacopeia Commission of China,
来源：
Journal of Translational Medicine | / 10卷 / Suppl 2期
关键词：
Health Care Policy; Excess Capacity; Society Development; Life Safety; Strategic Thinking;
D O I：
10.1186/1479-5876-10-S2-A39
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] DRUG ADMINISTRATION IN CHINA
    不详
    PHARMACY INTERNATIONAL, 1984, 5 (11): : 266 - 266
  • [32] Drug Addiction in China
    Lu, Lin
    Wang, Xi
    ADDICTION REVIEWS 2008, 2008, 1141 : 304 - 317
  • [33] Drug abuse in China
    Zhao, CZ
    Liu, ZM
    Zhao, D
    Liu, YH
    Liang, JH
    Tang, YL
    Liu, ZY
    Zheng, JW
    CURRENT STATUS OF DRUG DEPENDENCE / ABUSE STUDIES: CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY, 2004, 1025 : 439 - 445
  • [34] Drug discovery in China
    Nature Reviews Drug Discovery, 2008, 7 (10) : 869 - 869
  • [35] The Evolving Regulatory Landscape for Fentanyl: China, India, and Global Drug Governance
    Wang, Chao
    Lassi, Nicholas
    Zhang, Xiaohan
    Sharma, Vinay
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
  • [36] SCIENTIFIC AND REGULATORY PERSPECTIVES ON DRUG INTERACTION EVALUATION DURING DRUG DEVELOPMENT
    Zhang, Lei
    DRUG METABOLISM REVIEWS, 2014, 45 : 18 - 18
  • [37] REGULATORY WATCH Characteristics of expedited programmes for cancer drug approval in China
    Li, Guanqiao
    Liu, Yang
    Xie, Cuicui
    Zhou, Qing
    Chen, Xiaoyuan
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (06) : 416 - 416
  • [38] Correction to: The Reform of the Orphan Drug Assessment System in China
    Xiangyu Wang
    Lin Wang
    Xiaoying Zheng
    Qiang Zheng
    Journal of Pharmaceutical Innovation, 2022, 17 (3) : 1069 - 1069
  • [39] Characteristics and outcomes of the drug patent linkage system in China
    Yao, Xue-Fang
    GLOBALIZATION AND HEALTH, 2024, 20 (01)
  • [40] Recent update on drug patent linkage system in China
    Han, Weiwei
    PHARMACEUTICAL PATENT ANALYST, 2022, 11 (02) : 33 - 35
12345